Surfactant replacement therapy in animal models of respiratory failure due to viral infection.
van 't Veen
A
A
Dept. of Anaesthesiology, Erasmus University Rotterdam, The Netherlands.
So
K L
KL
Lachmann
B
B
D000818:Animals; D002245:Carbon Dioxide / Q000097:blood; D004195:Disease Models, Animal; D009980:Influenza A virus; D008297:Male; D051379:Mice; D009976:Orthomyxoviridae Infections / Q000150:complications / Q000473:pathology / Q000503:physiopathology; D010100:Oxygen / Q000097:blood; D010222:Parainfluenza Virus 1, Human; D018184:Paramyxoviridae Infections / Q000150:complications / Q000473:pathology / Q000503:physiopathology; D011024:Pneumonia, Viral / Q000150:complications / Q000473:pathology / Q000503:physiopathology; D011663:Pulmonary Surfactants / Q000627:therapeutic use*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012128:Respiratory Distress Syndrome / Q000188:drug therapy; D012131:Respiratory Insufficiency / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D015656:Respiratory Mechanics / Q000502:physiology; D013500:Surface Tension
D011663:Pulmonary Surfactants; D002245:Carbon Dioxide; D010100:Oxygen